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Background: Meaning-focused coping may be at the core of adequate adjustment to life after cancer. Cancer
survivors who experience their life as meaningful are better adjusted, have better quality of life and psychological
functioning. Meaning-Centered Group Psychotherapy for Cancer Survivors (MCGP-CS) was designed to help patients
to sustain or enhance a sense of meaning and purpose in their lives. The aim of the proposed study is to evaluate
the effectiveness and cost-effectiveness of MCGP-CS.
Methods/Design: Survivors diagnosed with cancer in the last 5 years and treated with curative intent, are recruited
via several hospitals in the Netherlands. After screening, 168 survivors are randomly assigned to one of the three
study arms: 1. Meaning-Centered Group Psychotherapy (MCGP-CS) 2. Supportive group psychotherapy (SGP) 3. Care
as usual (CAU). Baseline assessment takes place before randomisation, with follow up assessments post-intervention
and at 3, 6 and 12 months follow-up. Primary outcome is meaning making (PMP, PTGI, SPWB). Secondary outcome
measures address quality of life (EORTC-30), anxiety and depression (HADS), hopelessness (BHS), optimism (LOT-R),
adjustment to cancer (MAC), and costs (TIC-P, EQ-5D, PRODISQ).
Discussion: Meaning-focused coping is key to adjustment to life after cancer, however, there is a lack of evidence
based psychological interventions in this area. Many cancer survivors experience feelings of loneliness and alienation,
and have a need for peer support, therefore a group method in particular, can be beneficial for sustaining or
enhancing a sense of meaning. If this MCGP-CS is effective for cancer survivors, it can be implemented in the practice
of psycho-oncology care.
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In the past decade, life expectancies of cancer patients
have increased significantly. Due to recent innovations
in early detection and treatment, many patients have
become cancer survivors and the population of cancer
survivors is growing [1,2].
Many cancer patients seem to experience the diagnosis
of cancer as a challenge to experiencing life as meaning-
ful, for instance due to shifted priorities in life, or phys-
ical hindrances in achieving goals. For some people, the
diagnosis of cancer can lead to the experience of life
with little or no meaning [3]. Meaning in life is strongly
associated to psychological well-being and is liable to
alteration after a negative experience like cancer [4-6].
Meaning-focused coping may be at the core of adequate
adjustment to cancer: cancer patients who experience
their life as meaningful are better adjusted, have better
quality of life and psychological functioning [4,7]. There-
fore, a meaning-focused psychological intervention might
be beneficial for cancer survivors to increase adequate
adjustment to life after cancer and prevent and decrease
psychological distress.
Several interventions for cancer patients focusing at
least partly on experiencing meaning in life have been
developed and evaluated. The outcomes of several evalu-
ation studies are promising with improved self esteem,
optimism, mood, sense of meaning, spiritual well-being
and decreased suffering after intervention. These studies
are, however, hampered by methodological limitations,
like high dropout rates, no control for the effects of
attention, insufficient information on the treatment proto-
col and short periods of follow up [8-17]. Most of the
studied interventions target cancer patients in the pallia-
tive phase. None of the described studies assess the cost-
effectiveness. To our knowledge there are no randomized
controlled trials on meaning-centered psychological inter-
ventions targeting cancer survivors.
In the proposed study, we aim to evaluate the ef-
fectiveness of a newly developed meaning-centered
group psychotherapy for cancer survivors, based on
the Meaning-Centered Group Psychotherapy (MCGP)
[18]. MCGP, developed by Breitbart and colleagues, is
grounded in Frankl’s work and was designed to help
patients with advanced cancer to sustain or enhance a
sense of meaning, peace and purpose in their lives, des-
pite the confrontation with death [18]. Frankl stated
that the will to meaning is the primary motivation of
humans [19-21]. He developed a meaning-centered ap-
proach in psychotherapy, called logotherapy, that focuses
on assisting people to detect their individual meaning
or purpose in life. A pilot randomized controlled trial
showed that MCGP is potentially beneficial for advanced
cancer patients for decreasing emotional and spiritual
suffering [11].In the present study, we adapted MCGP for cancer
survivors (MCGP-CS). Based on outcome of a focus
group study on 23 patients [22], and on the input of
two psychotherapists with expertise in this specific
area, we adjusted the MCGP manual to make it com-
pliant for cancer survivors. Through this focus group
study we obtained insight in how survivors experience
and talk about meaning in life, and in their perceived
need for help with meaning making. In addition, the
results indicated that some cancer survivors succeeded
in meaning making efforts and experienced sometimes
even more meaning in life than before diagnosis, while
others struggled with meaning making and expressed
an unmet need for help [22]. In preparation of the
randomized controlled trial (RCT) studying effective-
ness, the feasibility of the MCGP-CS protocol was
tested in a feasibility study among 11 participants, di-
vided over two groups. The outcomes of the feasibility
study were positive: patient satisfaction and compliance
were high [23].
Based on the results of these studies, the MCGP-CS
manual and protocol were finalized. An example of an
adjustment to Breitbart’s original MCGP for palliative
patients addresses attitudinal sources of meaning. In the
advanced cancer patient protocol, patients are asked to
respond to questions like ‘What would you consider a
good or meaningful death?’ ‘How can you imagine being
remembered by your loved ones?’ In the adjusted proto-
col for cancer survivors, they are asked to respond to
questions like ‘What are limitations in your life at the
moment?’ ‘How can you carry on in life, despite these
limitations?’ ‘What do you want to do now, that will
make you happy and satisfied when you to die later?’
Another change that has been made, based on expert
advices, is that every experiential exercise starts with a
brief meditation exercise, so feelings can be processed at
a deeper level.
The main goal of the present study is to assess effect-
iveness and cost-effectiveness of MCGP-CS, compared
to supportive group psychotherapy (SGP) and to care as
usual (CAU) among cancer survivors with psychological




This study is a prospective randomized controlled trial
with three study arms: MCGP-CS, SGP and CAU.
Cancer survivors are recruited in two different ways: via
several hospitals in the Netherlands (region Leiden and
Amsterdam) and via public media (i.e. advertisement on
websites of patient societies, and in magazines and local
newspapers). All cancer survivors who meet in- and ex-
clusion criteria are asked to participate. Survivors are
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three study arms. The baseline assessment takes place
before randomisation, with follow up assessments one
week post-intervention and at 3, 6 and 12 months
follow-up. Reasons for dropout are registered. The
study protocol, information brochure, questionnaires
and informed consent form are approved as a multi-
center study by the Medical Ethics Committee of the
Leiden University Medical Center. The design is illus-
trated in Figure 1.
Study sample
Inclusion criteria: cancer diagnosis in the last 5 years,
treated with curative intent, main treatment is
completed (i.e. surgery, radiotherapy, chemotherapy),Figure 1 Design of the RCT.ability to attend all therapy sessions, expressed need for
psychological help/support and at least one
psychosocial complaint (e.g. depressed mood, anxiety,
coping issues, life questions, meaning making problems,
relationship problems).
Exclusion criteria: severe cognitive impairment, current
psychological treatment and insufficient mastery of
Dutch language.
The criteria are ascertained during a telephonic interview
by a trained psychologist.
A study specific questionnaire comprises questions
about sociodemographic (age, gender, religious back-
ground, marital status, family situation, education level,
other important life events in the past 2 years) and clin-
ical characteristics (type of cancer, cancer treatment,
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at the first assessment, at baseline. Participants are asked
which study-condition has their preference; this will not
influence the assignment to the conditions.
Randomization
Cancer survivors who meet the inclusion criteria and
sign the informed consent, are allocated to a group.
When the group counts 8 survivors, the group is ran-
domly assigned by an independent researcher, through
blocked randomization with randomly selected block
sizes, to one of the three study arms.
Meaning-centered group psychotherapy targeting cancer
survivors (MCGP-CS)
Cancer survivors in the experimental study arm partici-
pate in MCGP-CS. The main purpose of the MCGP-CS
is to sustain or enhance a sense of meaning or purpose
in the patient’s life, in order to cope better with the con-
sequences of cancer. MCGP-CS is a manualized 8-week
intervention that makes us of didactics, group discussion
and experiental exercises that focus around themes re-
lated to meaning and cancer survivorship. The sessions
take two hours each and are held weekly. The partici-
pants use a workbook (called Life lessons portfolio) and
get homework assignments every week. MCGP-CS is led
by one psychotherapist with experience in treating pa-
tients with cancer. Each session addresses a specific
theme that is related to the concepts and sources of
meaning. The themes of the sessions are: 1. Concept and
sources of meaning, 2. Meaning before and after cancer,
3. The story of our life as a source of meaning: what
made us who we are today, 4. The story of our life as
a source of meaning: things we have done and want
to do in the future, 5. Attitudinal sources of meaning:
encountering life’s limitations, 6. Creative sources of
meaning: responsibility, courage and creativity, 7. Experi-
ental sources of meaning, 8. Termination: presentations
of our life lessons and goodbyes. Table 1 gives an over-
view of the themes of each session.
Supportive group psychotherapy (SGP)
The control condition is an 8-week social support group
following Payne et al. [24]. The sessions take two hours
and are held weekly. Each group is supervised by a
psychotherapist with experience in treating patients
with cancer. The psychotherapist has an uncondition-
ally positive regard and empathetic understanding,
stimulates patients to actively share their experiences,
and focuses on positive emotions, and expression of
feelings.
Each of the 8 sessions has a different theme, which is
mentioned at the beginning of the session. The themes
of the sessions are: 1. group members’ introductions,2. need for support, 3. coping with medical tests and com-
municating with physicians, 4. coping with family and
friends, 5. coping with work issues, 6. coping with body
image and physical functioning, 7. coping with the future,
8. termination: where do we go from here? Table 1 gives an
overview of the themes of each session.
Care as usual (CAU)
Cancer survivors assigned to the CAU study arm do not
participate in one of the group interventions. If a patient
in the CAU study arm asks the researcher for psycho-
logical help, he or she is referred to their General Practi-
tioner (GP). Health care uptake is closely monitored,
to enable detailed post-hoc description of what CAU
entailed exactly.
Treatment quality
In the MCGP-CS and the SGP study arms, after each
session, the psychotherapist writes a short summary of
the session where he/she notes whether the protocol
was followed. All group sessions are audio taped and
randomly selected audio fragments will be analysed by
the researchers to establish whether the therapy protocol
was followed correctly.
Outcome assessment
Outcomes measures include questionnaires on meaning,
quality of life, anxiety and depression, hopelessness, opti-
mism, mental adjustment to cancer, satisfaction with the
intervention, and sociodemographic and clinical charac-
teristics. Furthermore, a cost-evaluation will be carried
out. Patients can choose to complete questionnaires on-
line or via pen and paper. Primary outcomes are col-
lected at all time points (baseline, after one week, 3, 6,
and 12 months). Secondary outcome measures are col-
lected at baseline, after one week, 3 and 6 months. Cost
evaluation outcomes are collected at baseline, after 3, 6,
and 12 months). A complete overview of the outcome
measures is presented in Table 2.
Primary outcome measures
Meaning
The Dutch Personal Meaning Profile (PMP) is a 39-item
self assessment scale for measuring meaning in life and
comprises 5 subscales: religion, dedication to life, fair-
ness of life, goal-orientedness, relationships [25].
The Dutch Post Traumatic Growth Inventory (PTGI)
is a 21 item self assessment scale for measuring post-
traumatic growth and comprises 5 scales: relationships,
viewing new possibilities, personal strength, spirituality,
appreciation of life [26].
The Ryff ’s Scale of Psychological Well-being (SPWB)
is a 49 item questionnaire to assess a person’s level of posi-
tive functioning and well-being and comprises 6 scales:
Table 1 Session topics covered in MCGP-CS1 and SGP2
Session MCGP-CS SGP
1 Concept and sources of meaning Group member introductions
2 Meaning before and after cancer The need for support
3 The story of our life as a source of meaning: what made us who we are today Coping with the medical test and communicating
with providers
4 The story of our life as a source of meaning: things we have done and
want to do in the future
Coping with family and friends
5 Attitudinal sources of meaning: encountering life’s limitations Coping with vocational issues
6 Creative sources of meaning: responsibility, courage and creativity Coping with body image and physical functioning
7 Experiental sources of meaning Coping with the future
8 Termination: presentations of our life lessons and goodbyes Termination: Goodbyes and how do we go from here?
1Meaning-Centered Group Psychotherapy for Cancer Survivors.
2Supportive Group Psychotherapy.
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tive relationships, purpose in life, self-acceptance [27].
Secondary outcome measures
Quality of life
The 30-item EORTC QLQ-C30 (version 3.0) includes a
global HRQOL scale (2 items) and comprises 5 functional
scales: physical functioning (5 items), role functioning
(2 items), emotional functioning (4 items), cognitive func-
tioning (2 items) and social functioning (2 items). There
are three symptom scales (nausea and vomiting (2 items),
fatigue (3 items) and pain (2 items) and 6 single items re-
lating to dyspnoea, insomnia, loss of appetite, constipation,
diarrhoea and financial difficulties [28,29].Table 2 Outcome measures and instruments
Outcome measures Instrument
Primary1
Meaning Personal Meaning Profile (PMP) [24]
Post Traumatic Growth Post Traumatic Growth Inventory (PTGI) [25]
Positive psychological
functioning and wellbeing
Ryff’s Scale of Psychological Well-being
(SPWB) [26]
Secondary2
Quality of life 30-item EORTC QLQ-C30 (version 3.0) [27,28]
Anxiety and Depression Hospital Anxiety and Depression Scale
(HADS) [29]
Hopelessness Beck Hopelessness Scale (BHS) [30,31]
Optimism Life Orientation Test (LOT-R) [31,32]
Adjustment to cancer Mental Adjustment to Cancer (MAC) [20]
Cost evaluation3 Trimbos and iMTA questionnaire on




1Assessment at T0, T1, T2, T3, T4.
2Assessment at T0, T1, T2, and T3.
3Assessment at T0, T2, T3 and T4.Anxiety and depression
A validated Dutch version of the Hospital Anxiety and
Depression Scale (HADS) is used to assess emotional
distress. The HADS is a 14-item self-assessment scale
for measuring distress with two subscales, anxiety and
depression. The HADS was specifically designed for use in
the medically ill. The total HADS score ranges from 0 to
42, the subscales from 0 to 21. A score of >15 is used as an
indicator of a high level of psychological distress [30].
Hopelessness
The Dutch Beck Hopelessness Scale (BHS) is a 20 item
self-assessment scale for measuring hopelessness. The
scale consists of 20 statements about oneself which are
endorsed as true or false. The content of 11 statements is
hopeless, the content of 9 statements is hopeful [31,32].
Optimism
The Dutch Life Orientation Test (LOT-R), is a 10-item
self-assessment scale for measuring optimism. The scale
consists of 10 statements about oneself which are en-
dorsed on a 5-point likert scale (from 1 totally disagree
to 5 totally agree) [33,34].
Adjustment to cancer
Cognitive and behavioural response to cancer diagnosis
and treatment is determined by the Mental Adjustment to
Cancer (MAC) questionnaire. The MAC scale comprises
five subscales: Fighting Spirit, Helplessness/Hopelessness,
Anxious Preoccupation, Fatalism and Avoidance [20].
Satisfaction with the intervention
At T1, cancer survivors in both the MCGP-CS and SGP
study arms are asked to evaluate the strengths and weak-
nesses of the group training that they received and rate
their satisfaction with the content, duration, and quality
of the training and the trainers on a 15 item likert-scaled
questionnaire and on free text responses. Participants
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evaluation questions about the specific content of the
MCGP-CS protocol (their opinion on talking about mean-
ing, the homework assignments and the workbook).
Cost-evaluation
Direct medical and direct non-medical cost data are col-
lected with the Trimbos and iMTA questionnaire on
Costs associated with Psychiatric illness (TiC-P) [35,36].
Unit resource use (GP visits, hospital days, etc.) will be
multiplied by their appropriate integral cost prices.
An economic evaluation regarding work (loss) and
health care use will be conducted as a cost-utility ana-
lysis for (changes in) health-related quality of life as
assessed with the EQ-5D [37].
Indirect non-medical cost data related to production
losses through work loss days and work cutback days
will be sampled with the appropriate PRODISQ modules
[38]. Indicators of return to work (RTW) are: Time to
partial and to full RTW, meaning number of calendar
days between end of treatment and first day at work;
Time to full RTW corrected for partial RTW.
Sample size
Based on a priori power analyses for hierarchical multiple
regression, assuming a power of .80, Cohen’s d of .80 and
alpha of .05, each study condition will need at least 43 can-
cer survivors. We will anticipate for loss to follow-up of
30%, and will therefore need 56 cancer survivors per condi-
tion at baseline. In total, we will recruit 168 cancer survi-
vors during an inclusion period of 2.5 years.
Statistical analyses
Descriptive statistics, t-tests and Chi2 tests will be used
to determine whether patient characteristics are similar
across experimental conditions. Results will be reported
on an intention-to-treat basis. The Linear Mixed Model-
ing (LMM) procedure will be used to estimate missing
values. This procedure includes incomplete cases in the
analysis and employs restricted maximum likelihood
estimation to calculate parameter estimates. LMM as-
sumes that missing data are missing at random. LMM
will be used to investigate the longitudinal development
of meaning making in the three groups. The effect of
study condition will be tested using contrasts within the
LMM. Mediation analyses [39,40] will be used to test as
whether development in the patients’ meaning making
explains/mediates the expected improvement in psycho-
logical functioning in the MCGP condition.
Economic outcomes
For the economic evaluation we will make use of the
pertinent guidelines [36,41-43]. The societal perspective
will be taken encompassing intervention costs, directnon-medical costs and indirect costs. The latter is not
expected to be very important in the studied population,
which is characterised by unemployment, but the data
on production losses will be collected anyway. Production
losses will be economically valuated using the friction cost
method [44]. Costs and effects will be analysed simultan-
eously, incremental cost-effectiveness ratios (ICERs) will
be calculated and placed within 95% confidence intervals,
2,500 bootstrap replications of the ICERs will be projected
on a cost-effectiveness plane, ICER acceptability curves
will be plotted against different willingness-to-pay ceilings
[45], and sensitivity analysis will be conducted as a matter
of course focussing on uncertainty in the main cost-
drivers. This will be done for the costs per QALY gained
in a cost utility analysis.
Ethical considerations
This study is conducted in accordance with local laws
and regulations. Eligible patients are fully informed
about the study and asked to participate. The patients re-
ceive a patient information sheet and flyer and they are
also informed by telephone about the implications of par-
ticipation. Patients have ample opportunity to ask ques-
tions and to consider the implications of the study before
deciding to participate. Patients provide written informed
consent, compliant with the local and ethical regulations,
before participation. Patients are allowed to withdraw
from the study without giving a reason, at any time. The
study protocol has been approved by the Medical Ethical
Committee of Leiden University Medical Center, Leiden,
The Netherlands.
Discussion
The proposed study will assess the effectiveness of
MCGP-CS, compared to SGP and to CAU in cancer survi-
vors with psychological or existential distress after treat-
ment. In addition, the cost-effectiveness of MCGP-CS will
be determined.
There is a growing need for psychological interven-
tions that target the issues that cancer survivors are
dealing with in the aftermath of their disease. Meaning-
focused coping is key to adjustment to life after cancer
[7,46]. Many cancer survivors experience feelings of loneli-
ness and alienation, and have a need for peer support,
therefore a group method in particular, can be beneficial
[47]. Group interventions may provide opportunities to
cope with these problems. People who benefit from group
interventions feel more comforted, less alone and have
learned different ways to cope with their situation [47].
To our knowledge there are no RCT’s that evaluate the
effectiveness of meaning-centered psychotherapy for can-
cer survivors. Also, there is little known about who benefits
from these types of interventions. Also, there is little
known on who benefits from these types of interventions.
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with a SGP that focuses on other issues that cancer survi-
vors deal with (see Table 2). This way, we hope to establish
whether a meaning-centered approach is more effective
compared to care as usual, than a non-meaning-centered
approach. Secondary analyses will be conducted to assess
the predictors of effectiveness on an individual level, in
order to gain more knowledge on which people benefit the
most from the meaning-centered intervention.
To our knowledge, there are no cost evaluations of
meaning-centered interventions. Since the number of
cancer survivors is increasing rapidly, cost efficient psy-
chological care is, from an economic point of view, im-
portant to warrant the feasibility of implementation in
mental health care settings.
This study evaluates if MCGP-CS is effective for can-
cer survivors and if so, whether this is a cost efficient
method. If this MCGP-CS is effective for cancer survi-
vors, it can be implemented in the practice of psycho-
oncology care. The broad collaboration in this project
with several hospitals and psycho-oncology organisa-
tions, facilitates possible implementation in practice after
this evaluation. There are few evidence based group
intervention manuals available for cancer patients. For
meaning-centered group psychotherapy for cancer survi-
vors, there are no evidence based intervention manuals
yet. Therefore, if the results of this RCT are positive on
effectiveness measures, the intervention protocol can be
an important addition to the advancement of evidence
based psychological care for cancer patients.
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